Time-Restricted Eating and Exercise for Bone Health (OSTEO-FIT)
2026年9月11日 更新者:Yi Lin、University of Alabama at Birmingham
Time-Restricted Eating and Exercise Training to Enhance Bone Health in Adults With Osteopenia
The purpose of this study is to learn whether combining time-restricted eating with supervised resistance exercise can improve bone health in adults with osteopenia.
研究概览
地位
尚未招聘
条件
研究类型
介入性
注册 (估计的)
24
阶段
- 不适用
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
Alabama
-
Birmingham、Alabama、美国、35294
- University of Alabama at Birmingham
-
接触:
- Yi Lin, PhD
- 电话号码:205.996.5876
- 邮箱:yilin@uabmc.edu
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
不
描述
Inclusion Criteria:
- Men and women aged 50-75 years with body mass index (BMI) >25kg/m2
- Osteopenia, defined as a T score between -1.0 and -2.5 at the lumbar spine, femoral neck, or total hip
- Elevated adiposity, defined by waist circumference >102 cm in men or >88 cm in women
- Stable health history over the past 2 months
- Stable medication history over the past 2 months, as recommended by the primary provider
- Willing and able to provide informed consent
Exclusion Criteria:
- Participation in a formal weight loss program, intentional caloric restriction, fasting >10 hours/day, or ≥10 pounds weight loss within the past 3 months
- Current participation in structured exercise training, supervised rehabilitation, or >150 minutes/week of moderate intensity physical activity
- Medical conditions or use of medications affecting bone metabolism
- Diagnosed diabetes or use of insulin or glucose lowering medications
- Resting heart rate >120 beats/minute or daytime blood pressure ≥180/100 mmHg
- Unstable angina, myocardial infarction, or stroke within the past 3 months
- Continuous supplemental oxygen use for chronic pulmonary disease or heart failure
- Rheumatoid arthritis, Parkinson's disease, dialysis, active cancer treatment within the past year, or diagnosed cognitive impairment
- Absolute contraindications to exercise training according to American College of Sports Medicine guidelines
- Unable to fast for 16 hours
- Any condition that in the opinion of the investigator would impair ability to participate in the trial
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Time-restricted eating combined with resistance exercise (TRE+Ex)
Participants in the TRE+Ex group will be asked to fast for a target of 16 hours per day, consuming food ad libitum within an 8-hour eating window beginning between 6:30 and 9:30 AM, 6 days per week for 12 weeks.
They will also complete supervised progressive resistance exercise training 3 days per week.
|
Participants in the TRE+Ex group will be asked to fast for a target of 16 hours per day, consuming food ad libitum within an 8-hour eating window beginning between 6:30 and 9:30 AM, 6 days per week for 12 weeks.
They will also complete supervised progressive resistance exercise training 3 days per week.
|
|
有源比较器:Habitual eating pattern combined with resistance exercise (HE+Ex)
Participants in the HE+Ex group will be instructed to maintain their habitual eating patterns and complete supervised progressive resistance exercise training 3 days per week.
|
Participants in the HE+Ex group will be instructed to maintain their habitual eating patterns and complete supervised progressive resistance exercise training 3 days per week.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Bone mineral density
大体时间:Baseline and 12 weeks
|
measured by dual-energy X-ray absorptiometry
|
Baseline and 12 weeks
|
|
Bone mineral content
大体时间:Baseline and 12 weeks
|
measured by dual-energy X-ray absorptiometry
|
Baseline and 12 weeks
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (估计的)
2026年11月1日
初级完成 (估计的)
2027年12月31日
研究完成 (估计的)
2028年4月30日
研究注册日期
首次提交
2026年9月11日
首先提交符合 QC 标准的
2026年9月11日
首次发布 (实际的)
2026年9月17日
研究记录更新
最后更新发布 (实际的)
2026年9月17日
上次提交的符合 QC 标准的更新
2026年9月11日
最后验证
2026年9月1日
更多信息
与本研究相关的术语
其他研究编号
- IRB-300017177
- UCEM-CAMBAC Joint Pilot Grant (其他赠款/资助编号:The University of Alabama at Birmingham)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
未定
IPD 计划说明
IPD may not be shared due to concerns regarding participant privacy and the sensitive nature of the health-related data collected.
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
不
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.